These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31976548)

  • 1. Tetramethylpyrazine: A promising drug for the treatment of pulmonary hypertension.
    Chen Y; Lu W; Yang K; Duan X; Li M; Chen X; Zhang J; Kuang M; Liu S; Wu X; Zou G; Liu C; Hong C; He W; Liao J; Hou C; Zhang Z; Zheng Q; Chen J; Zhang N; Tang H; Vanderpool RR; Desai AA; Rischard F; Black SM; Garcia JGN; Makino A; Yuan JX; Zhong N; Wang J
    Br J Pharmacol; 2020 Jun; 177(12):2743-2764. PubMed ID: 31976548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGB1 down-regulation mediates terameprocol vascular anti-proliferative effect in experimental pulmonary hypertension.
    Nogueira-Ferreira R; Ferreira-Pinto MJ; Silva AF; Vitorino R; Justino J; Costa R; Moreira-Gonçalves D; Quignard JF; Ducret T; Savineau JP; Leite-Moreira AF; Ferreira R; Henriques-Coelho T
    J Cell Physiol; 2017 Nov; 232(11):3128-3138. PubMed ID: 28036116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
    He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
    Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
    Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C
    Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratracheal Administration of Prostacyclin Analogue-incorporated Nanoparticles Ameliorates the Development of Monocrotaline and Sugen-Hypoxia-induced Pulmonary Arterial Hypertension.
    Akagi S; Nakamura K; Matsubara H; Kondo M; Miura D; Matoba T; Egashira K; Ito H
    J Cardiovasc Pharmacol; 2016 Apr; 67(4):290-8. PubMed ID: 26745002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.
    Grobs Y; Awada C; Lemay SE; Romanet C; Bourgeois A; Toro V; Nadeau V; Shimauchi K; Orcholski M; Breuils-Bonnet S; Tremblay E; Provencher S; Paulin R; Boucherat O; Bonnet S
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetramethylpyrazine Improves Monocrotaline-Induced Pulmonary Hypertension through the ROS/iNOS/PKG-1 Axis.
    Yang DP; Dong WP; Yang YC; Zeng YY; Liu Y; Dong Z; Ma XM; Cao YQ; Bai YZ; Yang B; Wang XW
    J Healthc Eng; 2022; 2022():1890892. PubMed ID: 35368928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats.
    Cao YY; Ba HX; Li Y; Tang SY; Luo ZQ; Li XH
    Life Sci; 2020 Jun; 250():117548. PubMed ID: 32173312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib alleviates experimental pulmonary hypertension by regulating intracellular calcium homeostasis in PASMCs.
    Zhang J; Lu W; Chen Y; Jiang Q; Yang K; Li M; Wang Z; Duan X; Xu L; Tang H; Sun D; Wang J
    Am J Physiol Cell Physiol; 2016 Sep; 311(3):C482-97. PubMed ID: 27413173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Potential of Regorafenib-A Multikinase Inhibitor in Pulmonary Hypertension.
    Veeroju S; Kojonazarov B; Weiss A; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Novoyatleva T; Schermuly RT
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
    Hosokawa S; Haraguchi G; Sasaki A; Arai H; Muto S; Itai A; Doi S; Mizutani S; Isobe M
    Cardiovasc Res; 2013 Jul; 99(1):35-43. PubMed ID: 23631839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
    Cheng Y; Yu M; Xu J; He M; Wang H; Kong H; Xie W
    BMC Pulm Med; 2018 Aug; 18(1):130. PubMed ID: 30086741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells.
    Gao L; Fan Y; Hao Y; Yuan P; Liu D; Jing Z; Zhang Z
    Int J Med Sci; 2017; 14(9):820-828. PubMed ID: 28824319
    [No Abstract]   [Full Text] [Related]  

  • 14. Tetramethylpyrazine inhibited hypoxia-induced expression of calcium-sensing receptors in pulmonary artery smooth muscle cells in chickens.
    Zhang H; Chang Z; Mehmood K; Yang MK; Liu Z; Duan Z; Yuan F; Ali MM; Adnan M; Qasim MU; Shaheen S; Abbas RZ; Tian Y; Guo R
    J Biol Regul Homeost Agents; 2018; 32(3):489-495. PubMed ID: 29921373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone Contributed to Pulmonary Arterial Hypertension Development via Stimulating Aquaporin Expression and Pulmonary Arterial Smooth Muscle Cells Proliferation.
    Wang Y; Zhong B; Wu Q; Zhu T; Wang Y; Zhang M
    Pharmacology; 2020; 105(7-8):405-415. PubMed ID: 31995798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
    Zhang MF; Liu XR; Yang N; Lin MJ
    Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bortezomib alleviates experimental pulmonary arterial hypertension.
    Kim SY; Lee JH; Huh JW; Kim HJ; Park MK; Ro JY; Oh YM; Lee SD; Lee YS
    Am J Respir Cell Mol Biol; 2012 Nov; 47(5):698-708. PubMed ID: 22842494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and pulmonary uric acid in pulmonary arterial hypertension.
    Savale L; Akagi S; Tu L; Cumont A; Thuillet R; Phan C; Le Vely B; Berrebeh N; Huertas A; Jaïs X; Cottin V; Chaouat A; Tromeur C; Boucly A; Jutant EM; Mercier O; Fadel E; Montani D; Sitbon O; Humbert M; Tamura Y; Guignabert C
    Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 33446602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study.
    Chen Y; He W; Ouyang H; Liu C; Hong C; Wang T; Yang K; Lu W; Wang J
    Trials; 2019 Dec; 20(1):725. PubMed ID: 31842950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.